Silicone Taping for the Improvement of Abdominal Donor Site Scars
Launched by NOVA SCOTIA HEALTH AUTHORITY · Aug 6, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether silicone tape can improve the appearance of scars after surgery. Specifically, it focuses on patients undergoing a type of surgery called abdominoplasty, which is often part of breast reconstruction. In this study, half of the surgical site will have silicone tape applied two weeks after the operation, while the other half will not have any dressing. Researchers want to see if using the silicone tape makes a noticeable difference in how the scars look over time.
To participate in this trial, candidates should be undergoing their first abdominoplasty as part of breast reconstruction. However, individuals with certain health conditions, such as skin diseases or allergies to adhesives, or those who smoke, are not eligible. Participants can expect regular follow-up visits to assess their scar healing and appearance, and the study aims to provide valuable information on the best ways to care for surgical scars.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • undergoing de novo abdominoplasty procedures as part of their breast reconstruction
- Exclusion Criteria:
- • patients with a history of collagen disease, connective tissue disorders, psoriasis or lupus
- • patients with scleroderma
- • patients with a history of adverse reaction to adhesives or silicone allergy
- • patients with signs of dehiscence or infection resulting in modification to the experimental or control dressings
- • patients who are unable to care for their incisions
- • patients who are current smokers
- • patients who are currently on steroids.
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Jason G Williams, MD
Principal Investigator
Nova Scotia Health Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials